Search research articles
Contact Us
Filters
Showing results (211-220 of 221) with videos related to
Page
of 23
Sort By:
Biomaterials
|
October 3, 2021
Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma
Yulin Zhang, Kaiyan Xi, Xiao Fu, et al.
Oncogenesis
|
March 16, 2018
Cigarette smoke stimulates the stemness of renal cancer stem cells via Sonic Hedgehog pathway
Weiwei Qian, Xiaochuan Kong, Tao Zhang, et al.
Clinical and Translational Medicine
|
April 16, 2026
Rezvilutamide plus docetaxel in chemotherapy-naive metastatic castration-resistant prostate cancer patients after progression on abiraterone: A multi-centre, open-label, phase II trial
Zhenhua Liu, Bo Chen, Tao Dai, et al.
Therapeutic Advances in Medical Oncology
|
December 30, 2024
Effectiveness, pharmacokinetics, and safety of triptorelin acetate microspheres in patients with locally advanced and metastatic prostate cancer
Guolan Wu, Feng Zhou, Haiping Wang, et al.
BMC Medicine
|
July 3, 2026
Structural-functional network decoupling in early stage amyotrophic lateral sclerosis reveals cell-type specific transcriptional signatures
Jixin Luan, Yan Yun, Yichang Jiao, et al.
Physiological Measurement
|
November 23, 2023
Magnetocardiography-based coronary artery disease severity assessment and localization using spatiotemporal features
Xiaole Han, Jiaojiao Pang, Dong Xu, et al.
Nature Communications
|
January 3, 2023
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
Song Li, Wenbin Yu, Fei Xie, et al.
Nature Communications
|
February 6, 2021
Efficacy and tolerability of bevacizumab in patients with severe Covid-19
Jiaojiao Pang, Feng Xu, Gianmarco Aondio, et al.
Nature Cancer
|
September 10, 2024
Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
Kaiwen Li, Wenlong Zhong, Jinhai Fan, et al.
BMC Medicine
|
May 9, 2025
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Xiaolin Lu, Tao Dai, Xue Chen, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 221) with videos related to
Sort By:
Page
of 23
Biomaterials
|
October 3, 2021
Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma
Yulin Zhang, Kaiyan Xi, Xiao Fu, et al.
Oncogenesis
|
March 16, 2018
Cigarette smoke stimulates the stemness of renal cancer stem cells via Sonic Hedgehog pathway
Weiwei Qian, Xiaochuan Kong, Tao Zhang, et al.
Clinical and Translational Medicine
|
April 16, 2026
Rezvilutamide plus docetaxel in chemotherapy-naive metastatic castration-resistant prostate cancer patients after progression on abiraterone: A multi-centre, open-label, phase II trial
Zhenhua Liu, Bo Chen, Tao Dai, et al.
Therapeutic Advances in Medical Oncology
|
December 30, 2024
Effectiveness, pharmacokinetics, and safety of triptorelin acetate microspheres in patients with locally advanced and metastatic prostate cancer
Guolan Wu, Feng Zhou, Haiping Wang, et al.
BMC Medicine
|
July 3, 2026
Structural-functional network decoupling in early stage amyotrophic lateral sclerosis reveals cell-type specific transcriptional signatures
Jixin Luan, Yan Yun, Yichang Jiao, et al.
Physiological Measurement
|
November 23, 2023
Magnetocardiography-based coronary artery disease severity assessment and localization using spatiotemporal features
Xiaole Han, Jiaojiao Pang, Dong Xu, et al.
Nature Communications
|
January 3, 2023
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
Song Li, Wenbin Yu, Fei Xie, et al.
Nature Communications
|
February 6, 2021
Efficacy and tolerability of bevacizumab in patients with severe Covid-19
Jiaojiao Pang, Feng Xu, Gianmarco Aondio, et al.
Nature Cancer
|
September 10, 2024
Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
Kaiwen Li, Wenlong Zhong, Jinhai Fan, et al.
BMC Medicine
|
May 9, 2025
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Xiaolin Lu, Tao Dai, Xue Chen, et al.
Page
of 23